Don’t Get Tricked by Trichomonas: A Neglected Sexually Transmitted Infection
You already have access to this webinar replay.
Please complete the following to have access to the full webinar:
Christina Muzny, MD, MSPH, FACP, FIDSA
Associate Professor of Medicine, Obstetrics/Gynecology, & Epidemiology
Vice Chair, UAB Institutional Review Board
Department of Medicine | Division of Infectious Diseases
Heersink School of Medicine | University of Alabama at Birmingham
Due to the challenges of traditional Trichomonas diagnostic methods, women with this infection may be undertreated. This can lead to adverse health outcomes, inability to initiate expedited partner treatment, and persistence of the infection in sexual networks.
In addition to providing updates on epidemiology, clinical relevance, and treatment recommendations, this webinar will examine the challenges associated with Trichomonas diagnosis, discuss issues surrounding drug resistance, and review patient management including the 2021 CDC guidelines for Trichomonas testing & treatment.
In this video, participants will:
- Review Trichomoniasis epidemiology – US and worldwide
- Examine adverse health outcomes for women
- Examine diagnosis and challenges associated
- Review issues surrounding drug resistance
- Review patient management – 2021 CDC guidelines for Trichomonas testing & treatment
- Evaluate a modern approach to outsmart Trichomonas
- Video recording replay
- Presentation Slides (PDF)
About the Presenter
Dr. Christina Muzny obtained her medical degree at the Texas A&M University Health Sciences Center College of Medicine. She subsequently completed an internal medicine residency and an infectious diseases fellowship at the University of Mississippi Medical Center prior to joining the infectious diseases faculty at the University of Alabama at Birmingham (UAB) in 2010. She has since obtained a Masters of Science in Public Health (Epidemiology) at the UAB School of Public Health.
Her clinical and research interests focus on the epidemiology, diagnosis, and treatment of HIV and sexually transmitted infections (STIs) in women, specifically vaginal infections including bacterial vaginosis (BV) and trichomoniasis. Dr. Muzny currently has R01 and R21 funding from NIH/NIAID to study the pathogenesis of BV. She has also recently participated in multiple clinical trials regarding use of 5-nitroimidazoles, including secnidazole, for the treatment of vaginal trichomoniasis in women.
Dr. Muzny is a tenured Associate Professor in the Division of Infectious Diseases at UAB with a secondary appointment in the UAB Department of Epidemiology. She is a medical consultant for the 2021 CDC STI Treatment Guidelines as well as a teaching faculty for the Alabama-North Carolina STD/HIV Prevention Training Center and an Associate Scientist for the UAB Center for AIDS Research.